InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,723.06
(
-0.26%
)
Post# of 11
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

hitekmastr

Send PM Follow Ignore
Followers 20
Posts 776
Boards Moderated 1
Alias Born 03/20/2020

hitekmastr

Re: None

Wednesday, 04/29/2020 3:23:06 PM

Wednesday, April 29, 2020 3:23:06 PM

Post# of 11
INO analysts INCREASED their price targets THIS WEEK after the MERS vaccine data was released, validating the company's vaccine development platform and showing strong dose results.

Cantor Fitzgerald analyst Charles Duncan reiterated an Overweight rating on Inovio and increased the price target from $13 to $17.

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and hiked the price target from $13 to $17.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up